NCT05543928Phase 3Terminated

Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism

Study sponsor: OPKO Health, Inc. · OPK

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-06-19Actual
Enrollment · participants2Actual
Source updated2025-07-25Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview